SHINE Technologies LLC will begin producing medical isotopes next year as it plans to increase cost effectiveness to eventually move its fusion technology into the recycling of nuclear waste and the fusion energy fields, CEO Greg Piefer said at the Wisconsin Entrepreneurs’ Conference Thursday.
Janesville-based SHINE is currently working toward production in its phase two of company development where it would make medical isotopes using small-scale nuclear transmutation, which converts one element into another. Medical isotopes have historically been produced in nuclear reactors that produce waste lasting thousands or millions of years, Piefer said at the conference.
“We’re laser-focused on being the biggest medical isotope production company in the world,” Piefer said.
;
